Tumor Immunogenicity

The Tumor microenvironment is an important aspect of cancer biology that contributes to Tumor initiation, Tumor progression and responses to therapy. Cells and molecules of the immune system are a fundamental component of the Tumor microenvironment. The ongoing battle between hosts and pathogens has long been of interest to evolutionary biologists. Because hosts and pathogens act as environments for each other, their intertwined struggle for existence is both continual and rapid. It is therefore little wonder that the host and pathogen genes that control infection and immunity frequently show high levels of genetic diversity and presents some of the best examples of positive selection (adaptive evolution) there are two main classifications of tumors. One is known as benign and the other as malignant. A benign Tumor is a Tumor that does not invade its surrounding tissue or spread around the body. A malignant Tumor is a Tumor that may invade its surrounding tissue or spread around the body.


    Related Conference of Tumor Immunogenicity

    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    July 29-30, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    November 12-13, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    November 14-15, 2019

    International Conference on Vaccines and Immune Response

    Istanbul, Turkey
    November 14-15, 2019

    Annual Congress on Antibiotics and Antimicrobial Resistance

    Geneva, Switzerland
    November 21-22, 2019

    World Conference on Vaccine and Immunology

    Dubai, UAE

    Tumor Immunogenicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in